APA (7th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. (2017). Patient group input submissions Brexpiprazole (Rexulti) (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.): Indication : treatment of schizophrenia in adults. Canadian Agency for Drugs and Technologies in Health.

Chicago Style (17th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. Patient Group Input Submissions Brexpiprazole (Rexulti) (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.): Indication : Treatment of Schizophrenia in Adults. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.

MLA (9th ed.) Citation

Canadian Agency for Drugs and Technologies in Health. Patient Group Input Submissions Brexpiprazole (Rexulti) (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.): Indication : Treatment of Schizophrenia in Adults. Canadian Agency for Drugs and Technologies in Health, 2017.